Alex Therapeutics

Private

StockholmHealthcare & Life Scienceshttps://alextherapeutics.com/

Last Round

Series A

Mar 3, 2023

Total Funding Raised

$9.24M

Company Overview

Alex Therapeutics is a healthtech company that develops and licenses clinically validated digital therapeutics (DTx) and companion apps in partnership with pharmaceutical companies.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Patient Engagement, Vertical SaaS, Compliance

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

digital therapeuticsDTxsoftware as a medical deviceSaMDprescription digital therapeuticsdigital health platformmedtech softwareregulatory complianceclinical validationAI therapy companionpatient engagement softwarevertical SaaShealth techdigital medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alex Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Alex Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Alex Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Mar 3, 2023
Series A	Apr 6, 2022
Grant	Jun 4, 2021
Seed	Jul 23, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

John Drakenberg

Founder & CEO

Founding Team

Max Körlinge

Chief Technology Officer

Executive Team

Kimmy Bolke

Chief Product Officer

Executive Team

Alex Therapeutics Investors

Notable investors and investment history

Alex Therapeutics investors
Investor	Rounds
Innovestor	Series A
Vinnova	Grant
Bonit Capital	Series A
Sweet Studio	Series A, Seed
Hadean Ventures	Series A
Scale Capital	Series A
Sweet Capital	Series A

View all Investors

Alex Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Alex Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Alex Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersStockholm

Employee Range35

Year Founded2018

Last FundingMar 3, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.